Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Cell Therapy Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The cell therapy market has expanded significantly in recent years. It is forecast to rise from $16.87 billion in 2025 to $19.31 billion in 2026, registering a compound annual growth rate (CAGR) of 14.5%. The historical growth of this market can be linked to the considerable expense of autologous therapies, difficulties in donor availability, the absence of standardized manufacturing, successful early-stage clinical trials, and the growing occurrence of chronic diseases.
The cell therapy market is projected for substantial expansion over the coming years. It is anticipated to reach a valuation of $32.48 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.9%. This projected increase during the forecast period stems from factors such as progress in gene editing, automation within cell manufacturing processes, increased funding for cell therapy startups, a rising need for regenerative medicine, and broader applications in oncology and cardiovascular disease (CVD). Key developments expected within this period encompass the evolution of personalized cell therapies, breakthroughs in allogeneic therapies, enhancements in cell storage and transportation, innovations in regulatory frameworks and compliance, and the emergence of new clinical uses.
Get A Free Sample Report With In-Depth Market Insights:
Cell Therapy Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The increasing occurrence of chronic illnesses fueled the expansion of the cell therapy market. The US Centers for Disease Control and Prevention (CDC) defines chronic disease as a long-term condition, persisting for at least one year, necessitating medical care, restricting daily functions, or both, encompassing ailments such as heart disease, cancer, diabetes, and Parkinson’s disease. Stem cells hold potential benefits for individuals with spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. Notably, in July 2024, the Centers for Disease Control and Prevention (CDC), a U.S. national public health body, issued key updates concerning public health efforts. Annually, more than 944,800 Americans succumb to heart disease or stroke, which represents over one-third of all fatalities. Each year in the U.S., 1.7 million individuals receive a cancer diagnosis, resulting in over 600,000 deaths, positioning it as the second leading cause of mortality. Furthermore, diabetes affects over 38 million Americans, with an additional 98 million adults categorized as prediabetic, elevating their susceptibility to type 2 diabetes. Serious complications such as heart disease, kidney failure, and blindness can arise from diabetes. Obesity impacts 20% of children and 42% of adults, thereby increasing the likelihood of chronic conditions like type 2 diabetes, heart disease, and specific cancers. This escalating prevalence of chronic diseases has boosted the demand for cell therapies, consequently fostering the growth of the cell therapy market.
Cell Therapy Market Segments: Where Is Growth Concentrated?
The cell therapy market covered in this report is segmented –
1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy
2) By Therapy Type: Allogeneic Therapies, Autologous Therapies
3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications
Subsegments:
1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy
2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine
3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy
4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy
5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy
Cell Therapy Market Innovation Trends Shaping Future Development
Leading companies within the cell therapy market are innovating next-generation, multi-targeted treatments, backed by robust early-stage clinical findings, aiming to boost therapeutic efficacy and address significant unmet needs in challenging cancers. An illustrative case is Johnson & Johnson, a pharmaceutical firm based in the US, which in June 2025, disclosed promising preliminary outcomes from its Phase 1b investigation of JNJ-4496. This particular therapy is a dual-targeting CAR T-cell approach engineered to engage both CD19 and CD20 for patients with relapsed or refractory large B-cell lymphoma. Initial data, unveiled at the 2025 EHA Congress, indicated impressive response rates, showing 75–80% complete responses at the recommended Phase 2 dose, critically without any Grade 3–4 cytokine release syndrome. The treatment demonstrated encouraging safety, manageable neurotoxicity, and potent activity even in individuals who had undergone extensive prior treatments. These discoveries underscore the promise of advanced dual-targeting CAR T strategies and reaffirm Johnson & Johnson’s commitment to advancing breakthrough treatments for B-cell malignancies.
Cell Therapy Market Key Participants And Competitive Landscape
Major companies operating in the cell therapy market are Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Athersys Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, Cellular Biomedicine Group Inc.
View The Full Cell Therapy Market Report:
Cell Therapy Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the cell therapy market in 2025. The regions covered in the cell therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model